Eyewire News: The Podcast

Eyewire News: The Podcast

Eyewire News: The Podcast keeps listeners updated with the latest information in the ophthalmic field, featuring breaking news from press releases, medical journals, vision publications, and other news sources.

Episodes

Alcon Acquires Staar for $1.5 Billion

August 6, 2025 • 13 mins
Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week.   Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Tryptyr Now Available in US

July 30, 2025 • 4 mins
Alcon launches its recently approved dry eye drug Tryptyr; a potential $1 billion deal is made to advance extended-release therapies for eye diseases; and two companies with late-stage AMD drug candidates complete phase 3 enrollment. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Harrow Adds Biosimilars to US Portfolio

July 23, 2025 • 4 mins
Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

AECOS Presentation Summaries

July 16, 2025 • 10 mins
Leading ophthalmologists share summaries of their presentations live from thee AECOS Summer Symposium.     Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Acquires LumiThera

July 9, 2025 • 6 mins
Alcon makes a major acquisition to bolster is vitreoretinal surgery portfolio; the European Commission (EC) approves Eylea 8 mg for extended treatment intervals; and Eric Donnenfeld, MD, discusses the business of myopia management. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Glaukos' MIGS Technology Certified in Europe; New Phase 3 Data for Presbyopia Drop

July 2, 2025 • 5 mins
Glaukos receives European Union certification for several of its MIGS technologies; Opus Genetics and Viatris present phase 3 results for their investigational presbyopia eye drop; and J&J launches the first and only daily disposable contact lens for people with both astigmatism and presbyopia.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Special Report: Update on Holland Foundation

June 25, 2025 • 8 mins
The leaders of the Holland Foundation provide an update on the progress of the foundation and its mission to restore sight for patients with Severe Ocular Surface Disease. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

TFOS DEWS III Published

June 18, 2025 • 5 mins
The Tear Film and Ocular Surface Society publishes the third installment of the TFOS DEWS report; J&J launches the Tecnis Odyssey presbyopia-correcting IOL in Europe, the Middle East, and Canada; and Harrow acquires the exclusive US commercial rights to postoperative inflammation and pain drug Byqlovi. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

First Myopia Drug Approved in Europe

June 11, 2025 • 4 mins
The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Gains FDA Approval for Novel DED Drug

June 4, 2025 • 8 mins
Alcon receives FDA approval for a novel pharmaceutical treatment for dry eye disease; Genentech’s Susvimo ocular implant is approval for a third indication in the US; and the makers of two investigational treatments for wet AMD complete enrollment in their respective phase 3 trials.  Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Special Report: Executives Discuss Overcoming Challenges

May 28, 2025 • 21 mins
Ophthalmology executives share challenging situations they encountered, as well as the steps needed to overcome the challenge. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

B+L Launches New Scleral Lenses Technology

May 21, 2025 • 3 mins
B+L launches a new scleral lenses technology in the US; New World Medical introduces a transparent tip on its Streamline Surgical System, and an OCT platform is cleared in Europe.   Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

B+L Receives Approval in Europe for LuxLife IOL

May 14, 2025 • 5 mins
Bausch + Lomb receives CE Mark for a new full range of vision IOL; Aldeyra plans to once again resubmit a new drug application to the FDA for dry eye drug candidate reproxalap; and Topcon makes several deals to advance its AI and digital health solutions Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Ophthalmic Leaders Launch SightLine Meeting

May 7, 2025 • 9 mins
Commercial stakeholders discuss the challenges and opportunities in ophthalmology in this special edition of Eyewire News: The Podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Breaking News from the ASCRS Meeting in Los Angeles

April 30, 2025 • 14 mins
EyewireTV reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery (ASCRS) meeting in Los Angeles. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

FDA Issues CRL to Regeneron for Eylea HD Extended Dosing

April 23, 2025 • 4 mins
The FDA responds to Regeneron’s request to extend dosing intervals for Eylea HD; Regeneron applies for a new indication for Eylea HD; and several recent executive appointments are announced in the ophthalmology industry.     Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Orasis Launches Presbyopia Eye Drop Qlosi

April 16, 2025 • 9 mins
A presbyopia drop is officially launched in the US; Nordic Pharma receives European approval for its novel dry eye therapy; and Tenpoint submits an NDA for a presbyopia eye drop candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Utilizing AI to Provide DR Screening to Underserved Communities

April 9, 2025 • 17 mins
EyewireTV speaks with the leaders of Digital Diagnostics and AEYE Health about their diabetic screening technology, racial and socioeconomic disparities in eye care, and their mission to improve health equity by expanding their technology into underserved populations. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Launches PanOptix Pro in US

April 2, 2025 • 6 mins
Alcon introduces its next-generation trifocal IOL; Alcon announces a deal to advance its clinical-stage allogeneic cell therapy; and Bausch + Lomb announces a voluntary recall of IOLs on its enVista platform. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Alcon Announces Plans to Acquire Lensar

March 26, 2025 • 5 mins
Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoices
Mark as Played

Popular Podcasts

    Stuff You Should Know

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    Dateline NBC

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Special Summer Offer: Exclusively on Apple Podcasts, try our Dateline Premium subscription completely free for one month! With Dateline Premium, you get every episode ad-free plus exclusive bonus content.

    On Purpose with Jay Shetty

    On Purpose with Jay Shetty

    I’m Jay Shetty host of On Purpose the worlds #1 Mental Health podcast and I’m so grateful you found us. I started this podcast 5 years ago to invite you into conversations and workshops that are designed to help make you happier, healthier and more healed. I believe that when you (yes you) feel seen, heard and understood you’re able to deal with relationship struggles, work challenges and life’s ups and downs with more ease and grace. I interview experts, celebrities, thought leaders and athletes so that we can grow our mindset, build better habits and uncover a side of them we’ve never seen before. New episodes every Monday and Friday. Your support means the world to me and I don’t take it for granted — click the follow button and leave a review to help us spread the love with On Purpose. I can’t wait for you to listen to your first or 500th episode!

    24/7 News: The Latest

    24/7 News: The Latest

    The latest news in 4 minutes updated every hour, every day.

    The Bobby Bones Show

    The Bobby Bones Show

    Listen to 'The Bobby Bones Show' by downloading the daily full replay.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

Explore

iHeart

Live Radio

Podcasts

Artist Radio

Exclusives

News

Features

Events

Contests

Photos

Information

About

Advertise

Blog

Brand Guidelines

Contest Guidelines

Subscription Offers

Jobs

Get the App

Automotive

Home

Mobile

Wearables

© 2025 iHeartMedia, Inc.